Characteristics of persistent urinary incontinence after successful fistula closure in Ethiopian women.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 21 12 2019
accepted: 12 02 2020
pubmed: 18 3 2020
medline: 24 6 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

Obstetric fistulas have devastating consequences for women. Although surgical repair is largely successful in closing the defect, many women with successful fistula closure report persistent urinary incontinence. Our study is aimed at characterizing incontinence after successful fistula repair and its impact on quality of life. This cross-sectional study enrolled women with a history of successful obstetric fistula closure with (n = 51; cases) or without (n = 50; controls) persistent urinary incontinence. Data were collected in Mekelle, Ethiopia, between 2016 and 2018. All cases underwent clinical evaluation and completed questionnaires characterizing the type, severity, and impact of incontinence. Cases were significantly more likely to have acquired their fistula at an earlier age and with their first vaginal delivery compared with controls. Almost all cases reported both stress (98%) and urgency (94%) incontinence, and half reported constant urinary leakage (49%) despite successful fistula closure. Of cases who completed urodynamic evaluation (n = 22), all had genuine stress incontinence and none had detrusor overactivity. All cases reported moderate to severe (80.4%) or very severe (19.6%) incontinence (measured by ICIQ-SF) and this had a moderate to severe negative impact on their quality of life (as measured by ICIQ-QoL). Although history of suicidal ideation was not significantly different between the groups, among those with suicidal ideation, cases were more likely to report having made a plan and/or attempted to commit suicide. When urinary incontinence persists after successful fistula closure, it tends to be severe and of mixed etiology and has a significant negative impact on quality of life and mental health.

Identifiants

pubmed: 32179937
doi: 10.1007/s00192-020-04265-w
pii: 10.1007/s00192-020-04265-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2277-2283

Subventions

Organisme : Worldwide Fistula Fund
ID : none

Références

Wright J, Ayenachew F, Ballard K. The changing face of obstetric fistula surgery in Ethiopia. Int J Womens Health Volume. 2016;8:243–8. https://doi.org/10.2147/IJWH.S106645 .
doi: 10.2147/IJWH.S106645
Bashah DT, Worku AG, Mengistu MY. Consequences of obstetric fistula in sub Sahara African countries, from patients’ perspective: a systematic review of qualitative studies. BMC Womens Health. 2018;18:106. https://doi.org/10.1186/s12905-018-0605-1 .
doi: 10.1186/s12905-018-0605-1 pubmed: 29925358 pmcid: 29925358
Arrowsmith SD, Barone MA, Ruminjo J. Outcomes in obstetric fistula care. Curr Opin Obstet Gynecol. 2013;25:399–403. https://doi.org/10.1097/GCO.0b013e3283648d60 .
doi: 10.1097/GCO.0b013e3283648d60 pubmed: 23892736 pmcid: 23892736
Hillary CJ, Chapple CR. The choice of surgical approach in the treatment of vesico-vaginal fistulae. Asian J Urol. 2018;5:155–9. https://doi.org/10.1016/j.ajur.2018.01.002 .
doi: 10.1016/j.ajur.2018.01.002 pubmed: 29988887 pmcid: 29988887
Muleta M. Obstetric fistulae: a retrospective study of 1210 cases at the Addis Ababa fistula hospital. J Obstet Gynaecol (Lahore). 1997;17:68–70. https://doi.org/10.1080/01443619750114194 .
doi: 10.1080/01443619750114194
Gessessew A, Mesfin M. Genitourinary and rectovaginal fistulae in Adigrat zonal hospital, Tigray, North Ethiopia. Ethiop Med J. 2003;41:123–30.
pubmed: 15227971 pmcid: 15227971
Browning A, Menber B. Women with obstetric fistula in Ethiopia: a 6-month follow up after surgical treatment. BJOG. 2008;115:1564–9. https://doi.org/10.1111/j.1471-0528.2008.01900.x .
doi: 10.1111/j.1471-0528.2008.01900.x pubmed: 19035992 pmcid: 19035992
Gutman RE, Dodson JL, Mostwin JL. Complications of treatment of obstetric fistula in the developing world: gynatresia, urinary incontinence, and urinary diversion. Int J Gynaecol Obstet. 2007;99(Suppl 1):S57–64. https://doi.org/10.1016/j.ijgo.2007.06.027 .
doi: 10.1016/j.ijgo.2007.06.027 pubmed: 17803995 pmcid: 17803995
Bengtson AM, Kopp D, Tang JH, Chipungu E, Moyo M, Wilkinson J. Identifying patients with vesicovaginal fistula at high risk of urinary incontinence after surgery. Obstet Gynecol. 2016;128:945–53. https://doi.org/10.1097/AOG.0000000000001687 .
doi: 10.1097/AOG.0000000000001687 pubmed: 27741181 pmcid: 27741181
Dolan L, Dixon W, Hilton P. Urinary symptoms and quality of life in women following urogenital fistula repair: a long-term follow-up study. BJOG. 2008;115:1570–4. https://doi.org/10.1111/j.1471-0528.2008.01927.x .
doi: 10.1111/j.1471-0528.2008.01927.x pubmed: 19035993
Goh JT, Krause H. Urinary incontinence following obstetric fistula repair. World J Obstet Gynecol. 2016;5:182. https://doi.org/10.5317/wjog.v5.i2.182 .
doi: 10.5317/wjog.v5.i2.182
Williams G, Browning A, Petros PE. The integral theory and its tethered vagina syndrome revisited: vaginal scarring may cause massive urinary incontinence. BJU Int. 2018;122(4):532–4. https://doi.org/10.1111/bju.14218 .
doi: 10.1111/bju.14218 pubmed: 29603848 pmcid: 29603848
Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;330:322–30. https://doi.org/10.1002/nau.20041 .
doi: 10.1002/nau.20041
Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynecol. 1997;104:1374–9.
Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn. 2009;28:411–5. https://doi.org/10.1002/nau.20674 .
doi: 10.1002/nau.20674 pubmed: 19214996 pmcid: 19214996
Borazjani A, Helina T, Ayenachew F, Goldman H, Wall LL. Evaluation of urinary frequency in patients with persistent urinary incontinence following successful closure of obstetric vesicovaginal fistula. Abstract, International Continence Society. 2014.
Browning A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG. 2006;113:482–5. https://doi.org/10.1111/j.1471-0528.2006.00875.x .
doi: 10.1111/j.1471-0528.2006.00875.x pubmed: 16489933 pmcid: 16489933
Goh JT, Krause H, Tessema AB, Abraha G. Urinary symptoms and urodynamics following obstetric genitourinary fistula repair. Int Urogynecol J. 2013;24:947–51. https://doi.org/10.1007/s00192-012-1948-z .
doi: 10.1007/s00192-012-1948-z pubmed: 23096530 pmcid: 23096530
Kopp DM, Bengtson AM, Tang JH, Chipungu E, Moyo M, Wilkinson J. Use of a postoperative pad test to identify continence status in women after obstetric vesicovaginal fistula repair: a prospective cohort study. BJOG. 2017;124:966–72. https://doi.org/10.1111/1471-0528.14505 .
doi: 10.1111/1471-0528.14505 pubmed: 28128507 pmcid: 28128507
Krhut J, Zachoval R, Smith PP, Rosier PFWM, Valanský L, Martan A, et al. Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn. 2014;33:507–10. https://doi.org/10.1002/nau.22436 .
doi: 10.1002/nau.22436 pubmed: 23797972
El Ayadi AM, Barageine J, Korn A, Kakaire O, Turan J, Obore S, et al. Trajectories of women’s physical and psychosocial health following obstetric fistula repair in Uganda: a longitudinal study. Trop Med Int Heal. 2019;24:53–64. https://doi.org/10.1111/tmi.13178 .
doi: 10.1111/tmi.13178
Wall LL, Arrowsmith SD. The “continence gap”: a critical concept in obstetric fistula repair. Int Urogynecol J. 2007;18:843–4. https://doi.org/10.1007/s00192-007-0367-z .
doi: 10.1007/s00192-007-0367-z

Auteurs

Rahel Nardos (R)

Worldwide Fistula Fund, Oregon Health & Science University/Kaiser Permanente, Mail code: L466, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA. nardosr@ohsu.edu.

Elena K Phoutrides (EK)

Contra Costa Regional Medical Center, Martinez, CA, USA.

Laura Jacobson (L)

School of Public Health, OHSU-PSU, Portland, OR, USA.

Allyson Knapper (A)

School of Medicine, Oregon Health & Science University, Portland, OR, USA.

Christopher K Payne (CK)

Vista Urology and Pelvic Pain Partners, Worldwide Fistula Fund, San Jose, CA, USA.

L Lewis Wall (LL)

Washington University, Worldwide Fistula Fund, St Louis, MI, USA.

Bharti Garg (B)

Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, USA.

Senait Tarekegn (S)

Healing Hands of Joy, Mekelle, Ethiopia.

Almaz Teamir (A)

Hamlin Fistula Center, Mekelle, Ethiopia.

Melaku Abriha Marye (MA)

Obstetrics and Gynecology, Hamlin Fistula Center, Mekelle, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH